An Immunohistochemical Assessment of Ki-67 and P53 Over-expression in Helicobacter pylori-positive Gastritis

Authors

  • Karam Turath Tawfeeq Department of Pathology, College of Medicine, University of Mosul, Mosul, Iraq
  • Elaf Abdulwahhab Hamdi Department of Pathology
  • Nadwa Subhi Al-Azzo Department of Pathology, College of Medicine, University of Mosul, Mosul, Iraq

DOI:

https://doi.org/10.3889/oamjms.2022.8054

Keywords:

Gastritis, Helicobacter pylori, Ki-67, P53

Abstract

AIM: Helicobacter pylori infection of the stomach is a common disease and the resulting changes from it are many and deserve to be in the focus of researchers’ attention, to assess the expression of mutant P53 protein and Ki-67 markers in patients with gastritis secondary to H. pylori.

METHODS: Thirty samples with positive H. pylori gastritis were included in a retrospective study in Mosul/Iraq. The histological parameters were assessed using the Sydney system, then, the expression of Ki-67 and P53 expression was studied by immunohistochemical methods. The significance level was appointed at (0.05).

RESULTS: Ki-67 and P53 expression were found in 83.3% of the total cases. The study results show that 92% of positive Ki-67 and P53 cases had chronic inflammatory cell infiltration, polymorph nuclear cells infiltration, and atrophy. Whereas 96% of positive Ki-67 cases had no metaplasia, 92% of the positive P53 cases had no metaplasia. The results also showed that only 16% of the positive Ki-67 cases had dysplastic changes, and 24% of the positive cases of P53 cases were showed dysplasia. whenever P53 was negative; there is neither metaplasia nor dysplasia in the tissue, this does not apply to Ki-67 negative cases.

CONCLUSIONS: Ki-67 and P53 expressions increase with chronicity of Helicobacter pylori-positive gastritis. P53 expression is amplified when atrophy is present in these samples.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Fischbach W, Malfertheiner P, Lynen Jansen P, Bolten W, Bornschein J, Buderus S, et al. S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease. Z Gastroenterol. 2016;54(4):327-63. https://doi.org/10.1055/s-0042-119653 PMid:27919112

Sipponen P, Maaroos HI. Chronic gastritis. Scand J Gastroenterol. 2015;50(6):657-67. https://doi.org/10.3109/00365521.2015.1019918 PMid:25901896

Kim KM, Oh YL, Ko JS, Choe YH, Seo JK. Histopathology and expression of Ki-67 and cyclooxygenase-2 in childhood Helicobacter pylori gastritis. J Gastroenterol. 2004;39(3):231-7. https://doi.org/10.1007/s00535-003-1282-9 PMid:15064999

Kamimura K, Kobayashi M, Sato Y, Aoyagi Y, Terai S. Collagenous gastritis: Review. World J Gastrointest Endosc. 2015;7(3):265-73. https://doi.org/10.4253/wjge.v7.i3.265 PMid:25789098

Kulnigg-Dabsch S. Autoimmune gastritis. Wien Med Wochensch (1946). 2016;166(13-14):424-30. https://doi.org/10.1007/s10354-016-0515-5 PMid:27671008

Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353-67. https://doi.org/10.1136/gutjnl-2015-309252 PMid:26187502

Watari J, Chen N, Amenta PS, Fukui H, Oshima T, Tomita T, et al. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol. 2014;20(18):5461-73. https://doi.org/10.3748/wjg.v20.i18.5461 PMid:24833876

Nayak VH, Engin NY, Burns JJ, Ameta P. Hypereosinophilic syndrome with eosinophilic gastritis. Global Pediatr Health. 2017;4:2333794X17705239. https://doi.org/10.1177/2333794X17705239 PMid:28491930

Rodriguez-Castro KI, Franceschi M, Miraglia C, Russo M, Nouvenne A, Leandro G, et al. Autoimmune diseases in autoimmune atrophic gastritis. Acta Biomed. 2018;89(8-S):100-3. https://doi.org/10.23750/abm.v89i8-S.7919 PMid:30561426

Wei J, Nagy TA, Vilgelm A, Zaika E, Ogden SR, Romero-Gallo J, et al. Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells. Gastroenterology. 2010;139(4):1333-43. https://doi.org/10.1053/j.gastro.2010.06.018 PMid:20547161

Mbulaiteye SM, Hisada M, El-Omar EM. Helicobacter pylori associated global gastric cancer burden. Front Biosci (Landmark edition). 2009;14:1490-504. https://doi.org/10.2741/3320 PMid:19273142

Al-Hassany HA, Albu-Rghaif AH, Naji MA. Tumor diagnosis by genetic markers protein P-53, p16, C-MYC, N-MYC, protein K-Ras, and gene her-2 Neu is this possible? Tumor diagnosis by genetic markers C-MYC, N-MYC, protein P-53, p16. Pak J Med Health Sci 2021;15(8):2350-4.

Tawfeeq KT, SHSA-T. P53 over-expression in urothelial carcinoma of the bladder: An immunohistochemical study. Med J Tikrit Univ 2012;18(182):189-211.

Salih BA, Gucin Z, Bayyurt N. A study on the effect of Helicobacter pylori infection on p53 expression in gastric cancer and gastritis tissues. J Infect Dev Ctries. 2013;7(9):651-7. https://doi.org/10.3855/jidc.2993 PMid:24042100

Shadifar M, Ataee R, Ataie A, Heydari Gorgi AM, Nasri Nasrabadi N, Nouri S. Genetic and molecular aspects of Helicobacter pylori in gastritis, pre- cancerous conditions and gastric adenocrcinoma. Gastroenterol Hepatol Bed Bench. 2015;8(Suppl 1):S15-22. PMid:26171133

Sun X, Kaufman PD. Ki-67: More than a proliferation marker. Chromosoma. 2018;127(2):175-86. PMid:29322240

Cabral MM, Oliveira CA, Mendes CM, Guerra J, Queiroz DM, Rocha GA, et al. Gastric epithelial cell proliferation and cagA status in Helicobacter pylori gastritis at different gastric sites. Scand J Gastroenterol. 2007;42(5):545-54. https://doi.org/10.1080/00365520601014034 PMid:17454874

Ikenberg H, Bergeron C, Schmidt D, Griesser H, Alameda F, Angeloni C, et al. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: Results of the PALMS study. J Natl Cancer Inst. 2013;105(20):1550-7. https://doi.org/10.1093/jnci/djt235 PMid:24096620

Petry KU, Schmidt D, Scherbring S, Luyten A, Reinecke- Lüthge A, Bergeron C, et al. Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology. Gynecol Oncol. 2011;121(3):505-9. https://doi.org/10.1016/j.ygyno.2011.02.033 PMid:21420158

Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, et al. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012;18(15):4154-62. https://doi.org/10.1158/1078-0432.CCR-12-0270 PMid:22675168

Ahadi M, Moradi A, Musavinejad L, Movafagh A, Moradi A. The expression of p53, CD44, Ki-67, and HER-2/ neu markers in gastric cancer and its association with histopathological indicators: A retrospective study. Asian Pac J Cancer Prev. 2020;21(6):1607-14. https://doi.org/10.31557/APJCP.2020.21.6.1607 PMid:32592354

Li N, Xie C, Lu NH. p53, a potential predictor of Helicobacter pylori infection-associated gastric carcinogenesis? Oncotarget. 2016;7(40):66276-86. https://doi.org/10.18632/oncotarget.11414

Mahmoudzadeh Sagheb H, Heidari Z, Jahantigh M, Narouei M. Immunohistochemical expression of p53 and Ki-67 genes in gastric cancer and precancerous lesions in the patients with Helicobacter pylori infection. Gene Cell Tissue. 2016;3(4):e41341.

Tiwari E, Pallipady A, Misra R, Mishra S. P53 and ki67 immunostaining in gastric biopsies: A histopathological study. Int J Sci Study 2015;2(11):96-101.

Azza Hegazi EH, El-Atrebi KA, El-Bassyouni HT. “P53 protein and Ki-67 expression in chronic gastritis patients with positive Helicobacter pylori infection”. J Gen Eng Biotechnol 2011;9(1): 73-76.

Gobbo César AC, de Freitas Calmon M, Cury PM, Caetano A, Borim AA, Silva AE. Genetic alterations in benign lesions: Chronic gastritis and gastric ulcer. World J Gastroenterol. 2006;12(4):625-9. https://doi.org/10.3748/wjg.v12.i4.625 PMid:16489680

Elnashar AT, Ahmed AR, Mohammed MH, Kamal GM. Immunohistochemical detection of P53 in Helicobacter pylori gastritis. Cancer Biol 2016;6(2):30-7.

Morales-Fuentes GA, Zarate-Osorno A, Quiñónez-Urrego EE, Antonio-Manrique M, Martínez-García CL, Figueroa-Barojas P, et al. p53 expression in the gastric mucosa of patients infected with Helicobacter pylori. Rev Gastroenterol Mexico. 2013;78(1):12-20. https://doi.org/10.1016/j.rgmx.2012.11.001 PMid:23374541

Aziz ZW, Saleem SH, Al-Nuaimy HA. Helicobacter pylori in gastric biopsy: A histochemical and immunohistochemical assessment. Ann Coll Med Mosul. 2020;41(2):139-47.

Forones NM, Carvalho AP, Giannotti-Filho O, Lourenço LG, Oshima CT. Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia. Arq Gastroenterologia. 2005;42(1):30-4. https://doi.org/10.1590/s0004-28032005000100008 PMid:15976908

Downloads

Published

2022-03-10

How to Cite

1.
Tawfeeq KT, Hamdi EA, Al-Azzo NS. An Immunohistochemical Assessment of Ki-67 and P53 Over-expression in Helicobacter pylori-positive Gastritis. Open Access Maced J Med Sci [Internet]. 2022 Mar. 10 [cited 2022 Jul. 1];10(A):535-9. Available from: https://oamjms.eu/index.php/mjms/article/view/8054